Quadrivalent Influenza Vaccine (QIV)

BIOLOGICAL5 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, Seqirus, Bayer, Pfizer

Conditions

Coronavirus Disease 2019 (COVID-19)InfluenzaInfluenza, HumanPregnancySARS-CoV-2 Infection

Phase 1

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

CompletedNCT05227001

PfizerInfluenza, Human

Start: 2022-04-28End: 2023-08-04Updated: 2026-03-20

A Study About Modified RNA Vaccines Against Influenza in Healthy Adults

CompletedNCT06436703

PfizerInfluenza, Human

Start: 2024-05-23End: 2025-02-05Updated: 2026-06-12

Phase 3

A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

CompletedNCT02214225

SeqirusInfluenza, Human

Start: 2014-08-31End: 2015-04-30Updated: 2017-03-13

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

WithdrawnNCT04848467

BayerCoronavirus Disease 2019 (COVID-19), SARS-CoV-2 Infection

Start: 2021-10-01End: 2022-11-15Updated: 2021-08-11

Unknown Phase

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

CompletedNCT01945424

Sanofi Pasteur, a Sanofi CompanyInfluenza, Pregnancy

Start: 2013-08-16End: 2019-09-15Updated: 2020-02-12

Related Papers

Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry

Influenza and Other Respiratory Viruses2021-09-1410 citations

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study

Vaccine2017-03-1334 citations